SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-050704
Filing Date
2020-04-24
Accepted
2020-04-24 09:08:48
Documents
3
Period of Report
2020-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016827-1_8k.htm 8-K 20002
2 EXHIBIT 99.1 tm2016827d1_ex99-1.htm EX-99.1 13497
3 GRAPHIC tm2016827d1_ex99-1img001.jpg GRAPHIC 4158
  Complete submission text file 0001104659-20-050704.txt   40624
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 20812711
SIC: 2834 Pharmaceutical Preparations